No | Age (years) | Gender | Factor of unresectability | Chemo-therapy | Radio-therapy | Reason of death | Survival (status) |
---|---|---|---|---|---|---|---|
1) | 50’s | M | Vascular (PV and HA)** | GS | 50.4Gy | Local tumor growth | 92.0 m (Dead) |
2) | 80’s | M | Biliary* + Vascular (PV and HA)** | GS | 36Gy | Other disease | 14.7 m (Dead) |
3) | 80’s | F | Biliary* + Vascular (HA)** | – | – | Local tumor growth | 3.1 m (Dead) |
4) | 70’s | M | Biliary* + Vascular (HA)** | GS | – | Dissemination Liver metastasis | 13.9 m (Dead) |
5) | 70’s | M | Vascular (HA)** | GS | – | Local tumor growth Liver metastasis | 21.6 m (Dead) |
6) | 60’s | M | Biliary* + Vascular (HA)** | GS → GC | – | Local tumor growth Lung metastasis | 18.5 m (Dead) |
7) | 60’s | M | Biliary* | GS | – | Local tumor growth Dissemination | 18.3 m (Dead) |
8) | 70’s | M | Biliary* | GS → GC | 36Gy | Local tumor growth, Dissemination | 16.7 m (Dead) |
9) | 70’s | M | Vascular (HA)** | – | – | Local tumor growth, Dissemination | 10.9 m (Dead) |
10) | 60’s | F | Biliary* | GS → GC | – | Local tumor growth Liver and bone metastasis | 16.7 m (Dead) |
11) | 40’s | F | Vascular (PV and HA)** | GS → GC | – | Local tumor growth Distant LN metastasis | 17.2 m (Dead) |
12) | 50’s | M | Vascular (PV and HA)** | G → GC | 45Gy | Dissemination Lung and bone metastasis | 24.0 m (Dead) |
13) | 70’s | M | Vascular (HA)** | GS → GC | – | – | 18.0 m (Alive) |
14) | 80’s | M | Vascular (HA)** | GS | – | – | 5.1 m (Alive) |